Bipartisan Congressional Lawmakers Tell DEA To Allow Psilocybin Treatment For Terminal Patients

Bipartisan members of Congress sent a letter on Tuesday requesting that the Drug Enforcement Administration (DEA) allow terminally ill patients to use psilocybin as an investigational treatment without the fear of federal prosecution.

Rep. Earl Blumenauer (D-OR) started circulating a Dear Colleague letter to build support for the request last month. Now signed by a coalition of lawmakers on both sides of the aisle, the letter to DEA stresses that there are state and federal right-to-try (RTT) laws that should make it so certain patients can obtain the psychedelic given that it’s shown early potential in ongoing clinical trials.

Read More on Marijuana Moment

Read Letter

About The Author

admin

Latest Blog Posts

Envisioning Drug Peace in the Entheogenic Reformation:

Envisioning Drug Peace in the Entheogenic Reformation:

Incorporating the Spiritual Geography of Psychoactives in Post-Prohibition Public Health  Greetings, I am Sunil Aggarwal, a doctor and medical geographer and a member of the Sacred Garden Community. I hail from Oklahoma, a child of Indian Immigrants, and I live today in Seattle, which rests on the unceded territory of the co-Salish Duwamish People, and I am so honored to join you here in Portland, a city which rests on the traditional village sites of the Multnomah, Wasco, Cowlitz, Kathlamet, Clackamas, Bands of Chinook, Tualatin, Kalapuya, Molalla, and many others who made their homes along the Columbia River. The title ...

Read More
The Healing Mind: Integrating Mental Health into Cancer Care

The Healing Mind: Integrating Mental Health into Cancer Care

By: Atara Jaffe, ND Feelings of anxiety and depression are common and often overlooked aspects of an individual’s experience in the cancer care process. At AIMS Institute, we provide integrative mental health care through a variety of modalities to approach body and mind. Our oncology team members that have proficiency in mental health include: Dr. Atara Jaffe, ND, Dr. Ksenia Malarkey, ND, Dr. Raushanah Najeeullah, ND, Dr. Monet Anthony, ND, Dr. Leanna Standish, ND, PhD. Our other team members also have experience and background with mental health services including: Dr. Emily Whinkin, ND, MS, Dr. Sunil Aggarwal, MD, PhD, Dr. ...

Read More
Impacts to Anxiety, Depression, and Psycho-Spiritual Metrics after Ketamine-Assisted Psychotherapy in Palliative Care Patients at the AIMS Institute

Impacts to Anxiety, Depression, and Psycho-Spiritual Metrics after Ketamine-Assisted Psychotherapy in Palliative Care Patients at the AIMS Institute

Author: Thomas Luedeke, Seattle University https://scholarworks.seattleu.edu/dnp-projects/95/ Date of Award 2024 Document Type Project College/School College of Nursing Degree Name Doctor of Nursing Practice (DNP) Project Mentor Therry Rose Eparwa Readers Conor Watters Abstract There is considerable evidence that palliative care patients disproportionately experience anxiety, depression, and existential distress related to their chronic illnesses. Additionally, conventional therapies tend to be less effective in the treatment of this patient population. As such, research is being conducted into novel therapies. One of the promising therapies currently under active investigation is ketamine-assisted psychotherapy (KAP) which involves a combination of the administration of the dissociative anesthetic ...

Read More
Call Us Text Us
Skip to content